In the October 2021 issue of On Drug Delivery, Stephen Perry and Nicholas Ciccarelli discuss the August 2021 acquisition of Neuma by Kymanox, highlighting how this acquisition has positioned Kymanox to lead the development of particularly complex drug delivery systems and cutting-edge medical device technologies.